Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (231-240 of 894) with videos related to

Pageof 90
Sort By:
Nature Reviews. Nephrology|August 14, 2014
Reply: Nephrons are generated via a series of committed progenitorsPaola Romagnani, Laura Lasagni, Giuseppe Remuzzi
Nephron. Clinical Practice|November 28, 2014
Rituximab in primary membranous nephropathy: first-line therapy, why not?Paolo Cravedi, Giuseppe Remuzzi, Piero Ruggenenti
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2017
Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?Marina Noris, Piero Ruggenenti, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 2, 2017
Clinical Translation of Mesenchymal Stromal Cell Therapies in NephrologyNorberto Perico, Federica Casiraghi, Giuseppe Remuzzi
Current Opinion in Organ Transplantation|November 22, 2013
Mesenchymal stromal cells to promote kidney transplantation toleranceFederica Casiraghi, Giuseppe Remuzzi, Norberto Perico
Nature Reviews. Nephrology|July 1, 2018
The role of B7-1 in proteinuria of glomerular originRubina Novelli, Ariela Benigni, Giuseppe Remuzzi
Current Opinion in Pharmacology|April 30, 2017
New biologics in the treatment of rare glomerular diseases of childhoodPaolo Cravedi, Andrea Angeletti, Giuseppe Remuzzi
Pediatric Nephrology (Berlin, Germany)|June 28, 2018
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathyMarina Noris, Roberta Donadelli, Giuseppe Remuzzi
Kidney International|May 29, 2020
The case of complement activation in COVID-19 multiorgan impactMarina Noris, Ariela Benigni, Giuseppe Remuzzi
American Journal of Disaster Medicine|March 2, 2019
Disaster medicine and response: Optimizing life-saving potentialMehmet Sukru Sever, Giuseppe Remuzzi, Raymond Vanholder
Pageof 90

Showing results (231-240 of 894) with videos related to

Sort By:
Pageof 90
Nature Reviews. Nephrology|August 14, 2014
Reply: Nephrons are generated via a series of committed progenitorsPaola Romagnani, Laura Lasagni, Giuseppe Remuzzi
Nephron. Clinical Practice|November 28, 2014
Rituximab in primary membranous nephropathy: first-line therapy, why not?Paolo Cravedi, Giuseppe Remuzzi, Piero Ruggenenti
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2017
Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?Marina Noris, Piero Ruggenenti, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 2, 2017
Clinical Translation of Mesenchymal Stromal Cell Therapies in NephrologyNorberto Perico, Federica Casiraghi, Giuseppe Remuzzi
Current Opinion in Organ Transplantation|November 22, 2013
Mesenchymal stromal cells to promote kidney transplantation toleranceFederica Casiraghi, Giuseppe Remuzzi, Norberto Perico
Nature Reviews. Nephrology|July 1, 2018
The role of B7-1 in proteinuria of glomerular originRubina Novelli, Ariela Benigni, Giuseppe Remuzzi
Current Opinion in Pharmacology|April 30, 2017
New biologics in the treatment of rare glomerular diseases of childhoodPaolo Cravedi, Andrea Angeletti, Giuseppe Remuzzi
Pediatric Nephrology (Berlin, Germany)|June 28, 2018
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathyMarina Noris, Roberta Donadelli, Giuseppe Remuzzi
Kidney International|May 29, 2020
The case of complement activation in COVID-19 multiorgan impactMarina Noris, Ariela Benigni, Giuseppe Remuzzi
American Journal of Disaster Medicine|March 2, 2019
Disaster medicine and response: Optimizing life-saving potentialMehmet Sukru Sever, Giuseppe Remuzzi, Raymond Vanholder
Pageof 90